Aurinia Pharmaceuticals Stock Cycle Indicators Hilbert Transform Trend vs Cycle Mode

AUPH Stock  USD 8.98  0.03  0.34%   
Aurinia Pharmaceuticals cycle indicators tool provides the execution environment for running the Hilbert Transform Trend vs Cycle Mode indicator and other technical functions against Aurinia Pharmaceuticals. Aurinia Pharmaceuticals value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of cycle indicators indicators. As with most other technical indicators, the Hilbert Transform Trend vs Cycle Mode indicator function is designed to identify and follow existing trends. Cycle Indicators are used by chartists in order to analyze variations of the instantaneous phase or amplitude of Aurinia Pharmaceuticals price series.

Indicator
The minimum time period for execution of this function requires larger time horizon. Please increase the time horizon for this function. The output start index for this execution was zero with a total number of output elements of zero. The Trend vs Cycle Mode is Hilbert Transform indicator that generates in-phase and quadrature components of Aurinia Pharmaceuticals price series in order to analyze trend vs cycle patterns of Aurinia Pharmaceuticals.

Aurinia Pharmaceuticals Technical Analysis Modules

Most technical analysis of Aurinia Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Aurinia from various momentum indicators to cycle indicators. When you analyze Aurinia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Aurinia Pharmaceuticals Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Aurinia Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aurinia Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Aurinia Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aurinia Pharmaceuticals's daily price indicators and compare them against related drivers, such as cycle indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Aurinia Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Aurinia Pharmaceuticals, we also check how macroeconomic factors affect Aurinia Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Payables Turnover0.281.833.272.2
Days Of Inventory On Hand6.5K1.6K1.0K1.1K
Hype
Prediction
LowEstimatedHigh
5.979.0412.11
Details
Intrinsic
Valuation
LowRealHigh
7.7210.7913.86
Details
7 Analysts
Consensus
LowTargetHigh
12.7414.0015.54
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.010.010.06
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run FinTech Suite Now

   

FinTech Suite

Use AI to screen and filter profitable investment opportunities
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
FinTech Idea
FinTech
Invested over 40 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 50 shares
Driverless Cars Idea
Driverless Cars
Invested over 200 shares
Business Services Idea
Business Services
Invested few shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Impulse Idea
Impulse
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Investing Idea
Investing
Invested few shares
Trump Equities Idea
Trump Equities
Invested few shares
When determining whether Aurinia Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aurinia Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aurinia Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aurinia Pharmaceuticals Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aurinia Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in Aurinia Stock please use our How to Invest in Aurinia Pharmaceuticals guide.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aurinia Pharmaceuticals. If investors know Aurinia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aurinia Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.15)
Revenue Per Share
1.536
Quarterly Revenue Growth
0.243
Return On Assets
(0.02)
Return On Equity
(0.06)
The market value of Aurinia Pharmaceuticals is measured differently than its book value, which is the value of Aurinia that is recorded on the company's balance sheet. Investors also form their own opinion of Aurinia Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Aurinia Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aurinia Pharmaceuticals' market value can be influenced by many factors that don't directly affect Aurinia Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aurinia Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aurinia Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aurinia Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.